docetaxel anhydrous has been researched along with sulindac sulfide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (sulindac sulfide) | Trials (sulindac sulfide) | Recent Studies (post-2010) (sulindac sulfide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 212 | 2 | 67 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | sulindac sulfide (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 2 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.05 | |
| Adenosine receptor A3 | Homo sapiens (human) | 7.231 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.231 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.4015 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.092 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.9182 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.231 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HG; Kang, Y; Kim, IY; Kim, JA; Park, SY; Thapa, D | 1 |
1 other study(ies) available for docetaxel anhydrous and sulindac sulfide
| Article | Year |
|---|---|
Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Survival; Colorectal Neoplasms; Docetaxel; Genes, p53; Growth Differentiation Factor 15; HCT116 Cells; HT29 Cells; Humans; Molecular Targeted Therapy; Sulindac; Taxoids; Tumor Suppressor Protein p53; Up-Regulation | 2011 |